Ignite Creation Date:
2024-05-05 @ 11:20 AM
Last Modification Date:
2024-10-26 @ 9:05 AM
Study NCT ID:
NCT00006471
Status:
COMPLETED
Last Update Posted:
2018-11-01
First Post:
2000-11-06
Brief Title:
Fenretinide in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
Sponsor:
MD Anderson Cancer Center
Organization:
MD Anderson Cancer Center
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Head and Neck Cancer |
Keywords:
| Name | View |
|---|---|
| untreated metastatic squamous neck cancer with occult primary | View |
| recurrent metastatic squamous neck cancer with occult primary | View |
| metastatic squamous neck cancer with occult primary squamous cell carcinoma | View |
| stage IV squamous cell carcinoma of the lip and oral cavity | View |
| recurrent squamous cell carcinoma of the lip and oral cavity | View |
| stage IV squamous cell carcinoma of the oropharynx | View |
| recurrent squamous cell carcinoma of the oropharynx | View |
| recurrent squamous cell carcinoma of the nasopharynx | View |
| stage IV squamous cell carcinoma of the hypopharynx | View |
| recurrent squamous cell carcinoma of the hypopharynx | View |
| stage IV squamous cell carcinoma of the larynx | View |
| recurrent squamous cell carcinoma of the larynx | View |
| stage IV squamous cell carcinoma of the paranasal sinus and nasal cavity | View |
| recurrent squamous cell carcinoma of the paranasal sinus and nasal cavity | View |
| stage IV squamous cell carcinoma of the nasopharynx | View |